Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001104659-24-099854
Filing Date
2024-09-13
Accepted
2024-09-13 17:06:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3175
  Complete submission text file 0001104659-24-099854.txt   4696
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38129 | Film No.: 241298525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address
Huber Martin H. Jr. (Reporting) CIK: 0001653276 (see all company filings)

Type: 144